{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:39:46Z","timestamp":1773056386350,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003441","name":"Universitair Ziekenhuis Gent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Statins are frequently prescribed to older adults, yet their effects on ageing phenotypes such as frailty or physiological reserves remain poorly understood. Gait Speed Reserve (GSR), defined as the difference between maximal and usual gait speeds, serves as an indicator of physiological reserve, reflecting the body\u2019s ability to perform beyond baseline functional levels. Polypharmacy, prevalent in this population, may contribute to inconsistent findings through interactions between statins and concomitant medications. We aimed to investigate how concomitant medications moderate the association between statin use and GSR in older adults. To this end, we conducted a cross-sectional observational cohort study using data from the Mobility Center at the University Department of Geriatric Medicine FELIX PLATTER, Basel, Switzerland (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20095519 adults aged\u2009\u2265\u200960\u00a0years). Moderation regression analyses with propensity score weighting were used to evaluate the effect of concomitant medications on the association between statin use and GSR. Results showed statin use was associated with a lower GSR compared to non-use (\u2212\u20091.9\u00a0cm\/s [95% CI,\u2009\u2212\u20093.1 to\u2009\u2212\u20090.72]). However, ACE inhibitors and aspirin significantly influenced this association. The GSR difference for statin users compared to non-users increased by 3.7\u00a0cm\/s (from\u2009\u2212\u20092.2 to 1.5\u00a0cm\/s; 95% CI, 0.0 to 7.4) with concomitant ACE inhibitor use and by 5.8\u00a0cm\/s (from\u2009\u2212\u20093.4 to 2.3\u00a0cm\/s; 95% CI, 2.5 to 9.1) with aspirin use. We found no statistically significant association between statin use and usual gait speed, the secondary outcome. In conclusion, ACE inhibitors and aspirin interacted with statins, reversing the negative association with GSR into a positive one when co-used. Future clinical trials are needed to determine causality and further investigate the impact of concomitant medication use on statin effects in aging populations. Meanwhile, our findings underscore the importance of considering concomitant medication use when assessing the effects of statins in older adults.\n                  <\/jats:p>","DOI":"10.1007\/s11357-025-01682-x","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T02:37:07Z","timestamp":1746585427000},"page":"777-792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The association between statins and gait speed reserve in older adults: effects of concomitant medication"],"prefix":"10.1007","volume":"48","author":[{"given":"Anton","family":"De Spiegeleer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoon","family":"Bronselaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ine","family":"Mahieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorien","family":"Vreys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Haslbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Philipp","family":"Leibfarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Van Schoote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aster","family":"Wakjira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Wynendaele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"De Spiegeleer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nele","family":"Van Den Noortgate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reto W.","family":"Kressig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6763-0694","authenticated-orcid":false,"given":"Roland","family":"R\u00f6ssler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"1682_CR1","unstructured":"WHO. Ageing and health. Accessed October 26th, 2024. https:\/\/www.who.int\/health-topics\/ageing#tab=tab_1"},{"issue":"4","key":"1682_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/jcsm.12051","volume":"6","author":"R Calvani","year":"2015","unstructured":"Calvani R, Marini F, Cesari M, et al. Biomarkers for physical frailty and sarcopenia: state of the science and future developments. Review Journal of Cachexia Sarcopenia and Muscle. 2015;6(4):278\u201386. https:\/\/doi.org\/10.1002\/jcsm.12051.","journal-title":"Review Journal of Cachexia Sarcopenia and Muscle"},{"issue":"8","key":"1682_CR3","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s12603-021-1629-z","volume":"25","author":"J Chhetri","year":"2021","unstructured":"Chhetri J, Xue Q, Ma L, Chan P, Varadhan R. Intrinsic capacity as a determinant of physical resilience in older adults. J nutri health & aging. 2021;25(8):1006\u201311. https:\/\/doi.org\/10.1007\/s12603-021-1629-z.","journal-title":"J nutri health & aging"},{"issue":"8","key":"1682_CR4","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/jgs.15233","volume":"66","author":"H Whitson","year":"2018","unstructured":"Whitson H, Cohen H, Schmader K, Morey M, Kuchel G, Colon-Emeric C. Physical resilience: not simply the opposite of frailty. J American Geriatrics Soc. 2018;66(8):1459\u201361. https:\/\/doi.org\/10.1111\/jgs.15233.","journal-title":"J American Geriatrics Soc"},{"issue":"8","key":"1682_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41573-020-0067-7","volume":"19","author":"L Partridge","year":"2020","unstructured":"Partridge L, Fuentealba M, Kennedy BK. The quest to slow ageing through drug discovery. Nat Rev Drug Discov. 2020;19(8):513\u201332. https:\/\/doi.org\/10.1038\/s41573-020-0067-7.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1682_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: AN expanding universe. Cell. 2023;186(2):243\u201378. https:\/\/doi.org\/10.1016\/j.cell.2022.11.001.","journal-title":"Cell"},{"key":"1682_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01318-6","author":"B Lindholm","year":"2024","unstructured":"Lindholm B, Basna R, Ekstr\u00f6m H, Elmst\u00e5hl S, Siennicki-Lantz A. Gait speed reserve in the general population-based \u2018Good Aging in Sk\u00e5ne\u2019 cohort study-distribution and associated factors. Geroscience. 2024. https:\/\/doi.org\/10.1007\/s11357-024-01318-6.","journal-title":"Geroscience"},{"key":"1682_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fnetp.2021.754477","volume":"1","author":"JRC Davis","year":"2021","unstructured":"Davis JRC, Knight SP, Donoghue OA, et al. Comparison of gait speed reserve, usual gait speed, and maximum gait speed of adults aged 50+ in Ireland using explainable machine learning. Front Netw Physiol. 2021;1: 754477. https:\/\/doi.org\/10.3389\/fnetp.2021.754477.","journal-title":"Front Netw Physiol"},{"key":"1682_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2022.111810","volume":"164","author":"K Ueno","year":"2022","unstructured":"Ueno K, Kamiya K, Hamazaki N, et al. Usefulness of measuring maximal gait speed in conjunction with usual gait speed for risk stratification in patients with cardiovascular disease. Exp Gerontol. 2022;164: 111810. https:\/\/doi.org\/10.1016\/j.exger.2022.111810.","journal-title":"Exp Gerontol"},{"issue":"12","key":"1682_CR10","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1093\/ndt\/gfad109","volume":"38","author":"S Yoshikoshi","year":"2023","unstructured":"Yoshikoshi S, Yamamoto S, Suzuki Y, et al. Reserved gait capacity and mortality among patients undergoing hemodialysis. Nephrol Dial Transplant. 2023;38(12):2704\u201312. https:\/\/doi.org\/10.1093\/ndt\/gfad109.","journal-title":"Nephrol Dial Transplant"},{"key":"1682_CR11","doi-asserted-by":"publisher","first-page":"111137","DOI":"10.1016\/j.exger.2020.111137","volume":"142","author":"A Garc\u00eda","year":"2020","unstructured":"Garc\u00eda A, R\u00f3denas I, Molina R, et al. Gait plasticity impairment as an early frailty biomarker. Exper Gerontol. 2020;142:111137. https:\/\/doi.org\/10.1016\/j.exger.2020.111137.","journal-title":"Exper Gerontol"},{"key":"1682_CR12","doi-asserted-by":"publisher","unstructured":"do Carmo Correia de Lima M, Loffredo Bilton T, Jefferson de Sousa Soares W, Paccini Lustosa L, Ferriolli E, Rodrigues PM. Maximum walking speed can improve the diagnostic value of frailty among community-dwelling older adults a cross-sectional study. The J Frailty Aging 2019;8(1):39\u201341 https:\/\/doi.org\/10.14283\/jfa.2018.44","DOI":"10.14283\/jfa.2018.44"},{"issue":"5","key":"1682_CR13","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s41999-023-00801-1","volume":"14","author":"T Hirai","year":"2023","unstructured":"Hirai T, Kamide N, Shigeta K. Decrease in maximum paced walking speed predicts hospitalization in community-dwelling older people with disabilities. Eur Geriatr Med. 2023;14(5):961\u20138. https:\/\/doi.org\/10.1007\/s41999-023-00801-1.","journal-title":"Eur Geriatr Med"},{"issue":"12","key":"1682_CR14","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1093\/ndt\/gfad109","volume":"38","author":"S Yoshikoshi","year":"2023","unstructured":"Yoshikoshi S, Yamamoto S, Suzuki Y, et al. Reserved gait capacity and mortality among patients undergoing hemodialysis. Nephrol Dial Transplant. 2023;38(12):2704\u201312. https:\/\/doi.org\/10.1093\/ndt\/gfad109.","journal-title":"Nephrol Dial Transplant"},{"key":"1682_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2020.111137","volume":"142","author":"A Noguer\u00f3n Garc\u00eda","year":"2020","unstructured":"Noguer\u00f3n Garc\u00eda A, Huedo R\u00f3denas I, Garc\u00eda Molina R, et al. Gait plasticity impairment as an early frailty biomarker. Exp Gerontol. 2020;142: 111137. https:\/\/doi.org\/10.1016\/j.exger.2020.111137.","journal-title":"Exp Gerontol"},{"key":"1682_CR16","doi-asserted-by":"publisher","unstructured":"do Carmo Correia de Lima M, Loffredo Bilton T, Jefferson de Sousa Soares W, Paccini Lustosa L, Ferriolli E, Rodrigues PM. Maximum walking speed can improve the diagnostic value of frailty among community-dwelling older adults a cross-sectional study. J Frailty Aging. 2019;8(1):39\u201341. https:\/\/doi.org\/10.14283\/jfa.2018.44","DOI":"10.14283\/jfa.2018.44"},{"key":"1682_CR17","doi-asserted-by":"publisher","unstructured":"Mellen RH, Girotto OS, Marques EB, et al. Insights into pathogenesis, nutritional and drug approach in sarcopenia: a systematic review. Biomedicines. 2023;11(1)https:\/\/doi.org\/10.3390\/biomedicines11010136","DOI":"10.3390\/biomedicines11010136"},{"key":"1682_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111638","volume":"141","author":"HV Sonaye","year":"2021","unstructured":"Sonaye HV, Sheikh RY, Doifode CA. Drug repurposing: iron in the fire for older drugs. Biomed Pharmacother. 2021;141: 111638. https:\/\/doi.org\/10.1016\/j.biopha.2021.111638.","journal-title":"Biomed Pharmacother"},{"key":"1682_CR19","doi-asserted-by":"publisher","unstructured":"Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109(23 Suppl 1):Iii39\u201343. https:\/\/doi.org\/10.1161\/01.CIR.0000131517.20177.5a","DOI":"10.1161\/01.CIR.0000131517.20177.5a"},{"issue":"4","key":"1682_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/01.Cir.0000080895.05158.8b","volume":"108","author":"MH Shishehbor","year":"2003","unstructured":"Shishehbor MH, Brennan ML, Aviles RJ, et al. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation. 2003;108(4):426\u201331. https:\/\/doi.org\/10.1161\/01.Cir.0000080895.05158.8b.","journal-title":"Circulation"},{"issue":"17","key":"1682_CR21","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.2165\/00003495-200363170-00005","volume":"63","author":"R Krysiak","year":"2003","unstructured":"Krysiak R, Okopie\u0144 B, Herman Z. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes. Drugs. 2003;63(17):1821\u201354. https:\/\/doi.org\/10.2165\/00003495-200363170-00005.","journal-title":"Drugs"},{"key":"1682_CR22","doi-asserted-by":"publisher","unstructured":"Morofuji Y, Nakagawa S, Ujifuku K, et al. Beyond lipid-lowering: effects of statins on cardiovascular and cerebrovascular diseases and cancer. Pharmaceuticals (Basel). 2022;15(2)https:\/\/doi.org\/10.3390\/ph15020151","DOI":"10.3390\/ph15020151"},{"key":"1682_CR23","doi-asserted-by":"crossref","unstructured":"De Spiegeleer A KH, Crombez L, Descamps A, R\u00f6ssler R, Kressig RW, et al. Potential role of statins in treatment of acute sarcopenia. Med Hypotheses. 2023;","DOI":"10.1016\/j.mehy.2023.111111"},{"issue":"21","key":"1682_CR24","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195\u2013207. https:\/\/doi.org\/10.1056\/NEJMoa0807646.","journal-title":"N Engl J Med"},{"issue":"8","key":"1682_CR25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2304146","volume":"389","author":"SK Grinspoon","year":"2023","unstructured":"Grinspoon SK, Fitch KV, Zanni MV, et al. Pitavastatin to prevent cardiovascular disease in HIV Infection. N Engl J Med. 2023;389(8):687\u201399. https:\/\/doi.org\/10.1056\/NEJMoa2304146.","journal-title":"N Engl J Med"},{"issue":"2","key":"1682_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/gerona\/glt140","volume":"69","author":"J Dumurgier","year":"2014","unstructured":"Dumurgier J, Singh-Manoux A, Tavernier B, Tzourio C, Elbaz A. Lipid-lowering drugs associated with slower motor decline in the elderly adults. J Gerontol A Biol Sci Med Sci. 2014;69(2):199\u2013206. https:\/\/doi.org\/10.1093\/gerona\/glt140.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"12","key":"1682_CR27","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1111\/jgs.12029","volume":"60","author":"SL Gray","year":"2012","unstructured":"Gray SL, Aragaki AK, LaMonte MJ, et al. Statins, angiotensin-converting enzyme inhibitors, and physical performance in older women. J Am Geriatr Soc. 2012;60(12):2206\u201314. https:\/\/doi.org\/10.1111\/jgs.12029.","journal-title":"J Am Geriatr Soc"},{"key":"1682_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.700776","volume":"12","author":"M Powell","year":"2021","unstructured":"Powell M, Koenecke A, Byrd JB, et al. Ten rules for conducting retrospective pharmacoepidemiological analyses: example COVID-19 study. Front Pharmacol. 2021;12: 700776. https:\/\/doi.org\/10.3389\/fphar.2021.700776.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1682_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40801-019-00175-6","volume":"7","author":"D Schnegg","year":"2020","unstructured":"Schnegg D, Senn N, Bugnon O, Schwarz J, Mueller Y. Drug prescription in older Swiss men and women followed in family medicine. Drugs-real world outcomes. 2020;7(1):87\u201395. https:\/\/doi.org\/10.1007\/s40801-019-00175-6.","journal-title":"Drugs-real world outcomes"},{"key":"1682_CR30","doi-asserted-by":"publisher","first-page":"739740","DOI":"10.3389\/fphar.2021.739740","volume":"12","author":"P Kardas","year":"2021","unstructured":"Kardas P, Lichwierowicz A, Urbanski F, Chudzynska E, Czech M, Kardas G. Prevalence of chronic polypharmacy in community-dwelling elderly people in Poland: analysis of national real-world database helps to identify high risk group. Front In Pharmacol. 2021;12:739740. https:\/\/doi.org\/10.3389\/fphar.2021.739740.","journal-title":"Front In Pharmacol"},{"key":"1682_CR31","unstructured":"GIP ZN. Top 10: Most Commonly used drug classes by polypharmacy patients aged 65 and over in 2023. 2024;"},{"issue":"1","key":"1682_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1109\/TFUZZ.2008.2008025","volume":"17","author":"A Bronselaer","year":"2009","unstructured":"Bronselaer A, De Tr\u00e9 G. A possibilistic approach to string comparison. IEEE Trans Fuzzy Syst. 2009;17(1):208\u201323. https:\/\/doi.org\/10.1109\/TFUZZ.2008.2008025.","journal-title":"IEEE Trans Fuzzy Syst"},{"key":"1682_CR33","doi-asserted-by":"publisher","unstructured":"Bronselaer A, De Tr\u00e9 G. Properties of possibilistic string comparison. iEEE Transac on Fuzzy Systems. 2010;18(2):312\u2013325. https:\/\/doi.org\/10.1109\/TFUZZ.2010.2041353","DOI":"10.1109\/TFUZZ.2010.2041353"},{"key":"1682_CR34","doi-asserted-by":"publisher","unstructured":"Zhao C, Sahni S. String correction using the Damerau-Levenshtein distance. BMC Bioinformatics. 2019;20(Suppl 11):277. https:\/\/doi.org\/10.1186\/s12859-019-2819-0","DOI":"10.1186\/s12859-019-2819-0"},{"issue":"2","key":"1682_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/bf03327437","volume":"18","author":"RW Kressig","year":"2006","unstructured":"Kressig RW, Beauchet O. Guidelines for clinical applications of spatio-temporal gait analysis in older adults. Aging Clin Exp Res. 2006;18(2):174\u20136. https:\/\/doi.org\/10.1007\/bf03327437.","journal-title":"Aging Clin Exp Res"},{"issue":"12","key":"1682_CR36","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/MLR.0000000000001922","volume":"61","author":"B Griffin","year":"2023","unstructured":"Griffin B, Schuler M, Cefalu M, et al. A tutorial for propensity score weighting for moderation analysis with categorical variables. Med Care. 2023;61(12):836\u201345. https:\/\/doi.org\/10.1097\/MLR.0000000000001922.","journal-title":"Med Care"},{"issue":"12","key":"1682_CR37","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/mlr.0000000000001922","volume":"61","author":"BA Griffin","year":"2023","unstructured":"Griffin BA, Schuler MS, Cefalu M, et al. A tutorial for propensity score weighting for moderation analysis with categorical variables: an application examining smoking disparities among sexual minority adults. Med Care. 2023;61(12):836\u201345. https:\/\/doi.org\/10.1097\/mlr.0000000000001922.","journal-title":"Med Care"},{"issue":"5","key":"1682_CR38","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1037\/a0036515","volume":"82","author":"KM Green","year":"2014","unstructured":"Green KM, Stuart EA. Examining moderation analyses in propensity score methods: application to depression and substance use. J Consult Clin Psychol. 2014;82(5):773\u201383. https:\/\/doi.org\/10.1037\/a0036515.","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"1682_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1037\/1082-989x.9.4.403","volume":"9","author":"DF McCaffrey","year":"2004","unstructured":"McCaffrey DF, Ridgeway G, Morral AR. Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychol Methods. 2004;9(4):403\u201325. https:\/\/doi.org\/10.1037\/1082-989x.9.4.403.","journal-title":"Psychol Methods"},{"key":"1682_CR40","unstructured":"Pane J, Griffin BA, Burgette L, McCaffrey D. OVtool - omitted variable tool. The Comprehensive R Archive Network. 2021;"},{"key":"1682_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/PHM.0000000000000488","volume":"95","author":"A Middleton","year":"2016","unstructured":"Middleton A, Fulk G, Herter T, Beets M, Donley J, Fritz S. Self-selected and maximal walking speeds provide greater insight into fall status than walking speed reserve among community-dwelling older adults. American J Physic Med & Rehab. 2016;95:475\u201382. https:\/\/doi.org\/10.1097\/PHM.0000000000000488.","journal-title":"American J Physic Med & Rehab"},{"key":"1682_CR42","doi-asserted-by":"publisher","first-page":"e0293729","DOI":"10.1371\/journal.pone.0293729","volume":"18","author":"E Gregg","year":"2023","unstructured":"Gregg E, Beggs C, Bissas A, Nicholson G. A machine learning approach to identify important variables for distinguishing between fallers and non-fallers in older women. Plos One. 2023;18:e0293729. https:\/\/doi.org\/10.1371\/journal.pone.0293729.","journal-title":"Plos One"},{"issue":"2","key":"1682_CR43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11357-017-9973-y","volume":"39","author":"ML Callisaya","year":"2017","unstructured":"Callisaya ML, Launay CP, Srikanth VK, Verghese J, Allali G, Beauchet O. Cognitive status, fast walking speed and walking speed reserve-the Gait and Alzheimer Interactions Tracking (GAIT) study. Geroscience. 2017;39(2):231\u20139. https:\/\/doi.org\/10.1007\/s11357-017-9973-y.","journal-title":"Geroscience"},{"issue":"21","key":"1682_CR44","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.3390\/jcm13216570","volume":"13","author":"A Prommaban","year":"2024","unstructured":"Prommaban A, Moonkayaow S, Phinyo P, Siviroj P, Sirikul W, Lerttrakarnnon P. The effect of exercise program interventions on frailty, clinical outcomes, and biomarkers in older adults: a systematic review. J Clinic Med. 2024;13(21):6570. https:\/\/doi.org\/10.3390\/jcm13216570.","journal-title":"J Clinic Med"},{"issue":"1","key":"1682_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/acr.22389","volume":"67","author":"G Peeters","year":"2015","unstructured":"Peeters G, Tett SE, Conaghan PG, Mishra GD, Dobson AJ. Is statin use associated with new joint-related symptoms, physical function, and quality of life? Results from two population-based cohorts of women. Arthritis Care Res (Hoboken). 2015;67(1):13\u201320. https:\/\/doi.org\/10.1002\/acr.22389.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1682_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/jgs.13134","volume":"63","author":"WH Lo-Ciganic","year":"2015","unstructured":"Lo-Ciganic WH, Perera S, Gray SL, et al. Statin use and decline in gait speed in community-dwelling older adults. J Am Geriatr Soc. 2015;63(1):124\u20139. https:\/\/doi.org\/10.1111\/jgs.13134.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"1682_CR47","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/ggi.13228","volume":"18","author":"H Kawai","year":"2018","unstructured":"Kawai H, Ihara K, Kera T, et al. Association between statin use and physical function among community-dwelling older Japanese adults. Geriatr Gerontol Int. 2018;18(4):623\u201330. https:\/\/doi.org\/10.1111\/ggi.13228.","journal-title":"Geriatr Gerontol Int"},{"issue":"12","key":"1682_CR48","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/j.1445-5994.2011.02622.x","volume":"42","author":"W Haerer","year":"2012","unstructured":"Haerer W, Delbaere K, Bartlett H, Lord SR, Rowland J. Relationships between HMG-CoA reductase inhibitors (statin) use and strength, balance and falls in older people. Intern Med J. 2012;42(12):1329\u201334. https:\/\/doi.org\/10.1111\/j.1445-5994.2011.02622.x.","journal-title":"Intern Med J"},{"issue":"10","key":"1682_CR49","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/gerona\/gly073","volume":"73","author":"T Strandberg","year":"2018","unstructured":"Strandberg T, Urtamo A, K\u00e4h\u00e4r\u00e4 J, Strandberg A, Pitk\u00e4l\u00e4 K, Kautiainen H. Statin Treatment is associated with a neutral effect on health-related quality of life among community-dwelling octogenarian men: the Helsinki businessmen study. J Gerontol Series a-Biol Sci Med Sci. 2018;73(10):1418\u201323. https:\/\/doi.org\/10.1093\/gerona\/gly073.","journal-title":"J Gerontol Series a-Biol Sci Med Sci"},{"issue":"5","key":"1682_CR50","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s41999-021-00472-w","volume":"12","author":"T Strandberg","year":"2021","unstructured":"Strandberg T, Lindstr\u00f6m L, Jyv\u00e4korpi S, Urtamo A, Pitk\u00e4l\u00e4 K, Kivim\u00e4ki M. Phenotypic frailty and multimorbidity are independent 18-year mortality risk indicators in older men: the Helsinki businessmen study (HBS). Euro Geriat Med. 2021;12(5):953\u201361. https:\/\/doi.org\/10.1007\/s41999-021-00472-w.","journal-title":"Euro Geriat Med"},{"issue":"8","key":"1682_CR51","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s40266-023-01045-1","volume":"40","author":"A Osman","year":"2023","unstructured":"Osman A, Speechley M, Ali S, Montero-Odasso M. Fall-risk-increasing drugs and gait performance in community-dwelling older adults: exploratory results from the gait and brain study. Drugs Aging. 2023;40(8):721\u201330. https:\/\/doi.org\/10.1007\/s40266-023-01045-1.","journal-title":"Drugs Aging"},{"issue":"1","key":"1682_CR52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/circulationaha.112.136101","volume":"127","author":"BA Parker","year":"2013","unstructured":"Parker BA, Capizzi JA, Grimaldi AS, et al. Effect of statins on skeletal muscle function. Circulation. 2013;127(1):96\u2013103. https:\/\/doi.org\/10.1161\/circulationaha.112.136101.","journal-title":"Circulation"},{"issue":"11","key":"1682_CR53","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/gerona\/glw057","volume":"71","author":"RM Henderson","year":"2016","unstructured":"Henderson RM, Lovato L, Miller ME, et al. Effect of statin use on mobility disability and its prevention in at-risk older adults: the LIFE study. J Gerontol A Biol Sci Med Sci. 2016;71(11):1519\u201324. https:\/\/doi.org\/10.1093\/gerona\/glw057.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1682_CR54","doi-asserted-by":"publisher","first-page":"100540","DOI":"10.1016\/j.ajpc.2023.100540","volume":"15","author":"S Qazi","year":"2023","unstructured":"Qazi S, Farah M, Charest B, et al. New statin use is associated with a lower risk of incident frailty in US veterans aged 65 years and older. American J Preventive Cardiol. 2023;15:100540. https:\/\/doi.org\/10.1016\/j.ajpc.2023.100540.","journal-title":"American J Preventive Cardiol"},{"key":"1682_CR55","doi-asserted-by":"publisher","unstructured":"de Vries M, Seppala LJ, Daams JG, van de Glind EMM, Masud T, van der Velde N. Fall-Risk-increasing drugs: a systematic review and meta-analysis: I. Cardiovascular Drugs. J Am Med Dir Assoc. 2018;19(4):371.e1\u2013371.e9. https:\/\/doi.org\/10.1016\/j.jamda.2017.12.013","DOI":"10.1016\/j.jamda.2017.12.013"},{"key":"1682_CR56","doi-asserted-by":"publisher","unstructured":"Ge J, Qin X, Yu X, et al. Amelioration of gait and balance disorders by rosuvastatin is associated with changes in cerebrovascular reactivity in older patients with hypertensive treatment. Hypertension Res 2024;https:\/\/doi.org\/10.1038\/s41440-024-01720-9","DOI":"10.1038\/s41440-024-01720-9"},{"issue":"11 Suppl 1","key":"1682_CR57","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1161\/01.Str.0000143319.73503.38","volume":"35","author":"M Endres","year":"2004","unstructured":"Endres M, Laufs U. Effects of statins on endothelium and signaling mechanisms. Stroke. 2004;35(11 Suppl 1):2708\u201311. https:\/\/doi.org\/10.1161\/01.Str.0000143319.73503.38.","journal-title":"Stroke"},{"issue":"21","key":"1682_CR58","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1042\/cs20210719","volume":"135","author":"J Kingsley","year":"2021","unstructured":"Kingsley J, Torimoto K, Hashimoto T, Eguchi S. Angiotensin II inhibition: a potential treatment to slow the progression of sarcopenia. Clin Sci (Lond). 2021;135(21):2503\u201320. https:\/\/doi.org\/10.1042\/cs20210719.","journal-title":"Clin Sci (Lond)"},{"key":"1682_CR59","doi-asserted-by":"publisher","first-page":"1117502","DOI":"10.3389\/fragi.2023.1117502","volume":"4","author":"V Bueno","year":"2023","unstructured":"Bueno V, Frasca D. Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer\u2019s disease, sarcopenia, cancer, and COVID-19. Front Aging. 2023;4:1117502. https:\/\/doi.org\/10.3389\/fragi.2023.1117502.","journal-title":"Front Aging"},{"issue":"2","key":"1682_CR60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/FJC.0b013e31825b61e2","volume":"60","author":"S Mitra","year":"2012","unstructured":"Mitra S, Wang X, Khaidakov M, et al. Aspirin downregulates angiotensin type 1 receptor transcription implications in capillary formation from endothelial cells. J Cardiovasc Pharmacol. 2012;60(2):187\u201392. https:\/\/doi.org\/10.1097\/FJC.0b013e31825b61e2.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1682_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101612","volume":"77","author":"F Gouveia","year":"2022","unstructured":"Gouveia F, Camins A, Ettcheto M, et al. Targeting brain renin-angiotensin system for the prevention and treatment of Alzheimer\u2019s disease: past, present and future. Ageing Res Rev. 2022;77: 101612. https:\/\/doi.org\/10.1016\/j.arr.2022.101612.","journal-title":"Ageing Res Rev"},{"issue":"7","key":"1682_CR62","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jamda.2020.06.018","volume":"21","author":"A De Spiegeleer","year":"2020","unstructured":"De Spiegeleer A, Bronselaer A, Teo JT, et al. The effects of ARBs, ACEis, and statins on clinical outcomes of COVID-19 infection among nursing home residents. J Am Med Dir Assoc. 2020;21(7):909-914.e2. https:\/\/doi.org\/10.1016\/j.jamda.2020.06.018.","journal-title":"J Am Med Dir Assoc"},{"issue":"10","key":"1682_CR63","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/sms.12572","volume":"26","author":"S van Ginkel","year":"2016","unstructured":"van Ginkel S, Ruoss S, Valdivieso P, et al. ACE inhibition modifies exercise-induced pro-angiogenic and mitochondrial gene transcript expression. Scand J Med Sci Sports. 2016;26(10):1180\u20137. https:\/\/doi.org\/10.1111\/sms.12572.","journal-title":"Scand J Med Sci Sports"},{"key":"1682_CR64","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.pmedr.2016.03.009","volume":"3","author":"PD Loprinzi","year":"2016","unstructured":"Loprinzi PD, Loenneke JP. The effects of antihypertensive medications on physical function. Prev Med Rep. 2016;3:264\u20139. https:\/\/doi.org\/10.1016\/j.pmedr.2016.03.009.","journal-title":"Prev Med Rep"},{"issue":"12","key":"1682_CR65","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jamainternmed.2022.5028","volume":"182","author":"AL Barker","year":"2022","unstructured":"Barker AL, Morello R, Thao LTP, et al. Daily low-dose aspirin and risk of serious falls and fractures in healthy older people: a substudy of the ASPREE randomized clinical trial. JAMA Intern Med. 2022;182(12):1289\u201397. https:\/\/doi.org\/10.1001\/jamainternmed.2022.5028.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"1682_CR66","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/jep.12158","volume":"20","author":"RW Bohannon","year":"2014","unstructured":"Bohannon RW, Glenney SS. Minimal clinically important difference for change in comfortable gait speed of adults with pathology: a systematic review. J Eval Clin Pract. 2014;20(4):295\u2013300. https:\/\/doi.org\/10.1111\/jep.12158.","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"1682_CR67","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1589\/jpts.31.75","volume":"31","author":"RW Bohannon","year":"2019","unstructured":"Bohannon RW. Minimal clinically important difference for grip strength: a systematic review. J Physic Therapy Sci. 2019;31(1):75\u20138. https:\/\/doi.org\/10.1589\/jpts.31.75.","journal-title":"J Physic Therapy Sci"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01682-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01682-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01682-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:23:55Z","timestamp":1773048235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01682-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1682"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01682-x","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}